Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

UBS

UBS is the world's largest wealth manager, a top tier investment banking and securities firm, and a key global asset manager. In Switzerland, UBS is the market leader in retail and commercial banking.UBS, headquartered in Zurich and Basel, is present in all major financial centers worldwide.
UBS's financial businesses employ over 70,000 people worldwide.UBS is one of the world's leading financial firms. UBS isthe world's leading wealth management businessa global investment banking and securities firm a key asset manager the market leader in Swiss corporate and individual client banking.
As an organization, UBS combines financial strength with a culture that embraces change. As an integrated firm, UBS creates added value for clients by drawing on the combined resources and expertise of all its businesses


Contact Details:
Bahnhofstr. 45, P.O. Box
Zurich
Schlieren
CH-8098
Switzerland
Tel:41-44-234 11 11
Fax:41-44-239 91 11
Email:
WWW:

www.ubs.com/




Recent Publications by UBS:

Liquid flow residence time in a fibrous fixed bed reactor with recycle.
Waste removal efficiency of gas-liquid biofilter reactors for waste water...
13th October, 2009
Laboratoire de Biotechnologie et Chimie Marine, Universite Europeenne de Bioresour Technol. 2010 Feb;101(4):1300-4. Epub 2009 Oct 9.
DOI Direct Link
Antifouling activity of macroalgal extracts on Fragilaria pinnata (Bacillariophyceae): a comparison with Diuron.
The tributyltin-based products and organic biocides which are incorporated...
4th September, 2009
Laboratoire de Biotechnologie et Chimie Marines (LBCM), Universite de Aquat Toxicol. 2009 Oct 4;94(4):245-54. Epub 2009 Jul 16.
DOI Direct Link
Decision making during preoperative surgical planning.
OBJECTIVE: This study analyzes decision making during preoperative...
26th August, 2009
University of Southern Brittany, Vannes, France. Hum Factors. 2009 Feb;51(1):67-77.
A stochastic filtering technique for fluid flow velocity fields tracking.
In this paper, we present a method for the temporal tracking of fluid flow...
23rd July, 2009
European University of Brittany-UBS, CNRS UMR 3192-Lab-STICC, BP 573, IEEE Trans Pattern Anal Mach Intell. 2009 Jul;31(7):1278-93.
DOI Direct Link
The receptivity of women to courtship solicitation across the menstrual cycle: a field experiment.
Research has demonstrated that women's behaviors toward men or sexual...
23rd May, 2009
Universite de Bretagne-Sud, UFR LSHS, 4 rue Jean Zay, BP 92116, 56321 Biol Psychol. 2009 Mar;80(3):321-4. Epub 2008 Nov 25.
DOI Direct Link

View more UBS research publications.

Press Releases on UBS:

BioPortfolio Logo
Bain Capital Agrees to Purchase BELLSYSYTEM24 from Citi 15th November, 2009 Bain Capital, LLC
TOKYO, Nov. 15 /PRNewswire/ -- Bain Capital today announced the signing of a definitive agreement to acquire Citigroup Inc.'s (NYSE: C) controlling stake in Japan's leading call center
Warner Chilcott Announces Secondary Equity Offering 13th November, 2009 Warner Chilcott plc
ARDEE, Ireland, Nov. 13 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The
HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 3rd November, 2009 HealthSouth Corporation
BIRMINGHAM, Ala., Nov. 3 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) today reported its results of operations for the third quarter ended September 30, 2009. The results showed
Cardinal Health Announces Final Results of Debt Tender Offer 25th September, 2009 Cardinal Health, Inc.
Principal Amount Principal
Somanetics Corporation To Present at UBS Global Life Sciences Conference and Maxim Group Growth Conference 21st September, 2009 Somanetics Corporation
-- UBS Global Life Sciences Conference Wednesday, September 23, 2009 10:00 a.m. ( ET) Grand Hyatt, New York, NY -- Maxim Group Growth Conference Tuesday, September 29, 2009 9:00 a.m.

BioNews Results for UBS:

Merrion Pharmaceuticals Selected To Present At Prestigious Ubs Global Life Sciences Conference
Pharmacy Choice:  Nov 14 2009 12:58PM Matching: ubs
WSJ(11/14) Eli Lilly Appoints New Chief Of
Morningstar UK:  Nov 13 2009 11:50PM Matching: ubs
US stocks advance
The Age:  Nov 13 2009 11:05PM Matching: ubs
MARKET TALK: UBS Lifts GlaxoSmithKline T
Hemscott:  Nov 12 2009 12:53PM Matching: ubs
FTSE flat as BT gains offset by commodity stocks
Reuters:  Nov 12 2009 10:11AM Matching: ubs
Promote your company here: BioNewsCast - Press Release Distribution

View more UBS news.

UBS Patents:

US Patent No.Title
7606747 Global compliance system
7356497 Systems, apparatus and methods for establishing a flat fee brokerage account system
7346667 System for delivering dynamic content
7343550 System and method for providing on-line services for multiple entities
7340430 Real-time trading system

View more UBS patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 367 times since April 2007, the link to the organisation's website has been followed 50 times

Recent Search Terms used to find this page: UBS strengths | ubs strengths | UBS patents | ch-8098 ZURICH POSTCODE | strengths of UBS | ubs strengths 2009 | .

Search for more companies in Zurich

Search for more companies in Schlieren



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for UBS

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.